Back
Liberty Formula One Group Vs. NovoCure Industry Stock Comparison
Sell
41
FWONK
Liberty Formula One Group
Last Price:
68.97
Seasonality Move:
11.18%
Sell
36
NVCR
NovoCure
Last Price:
12.23
Seasonality Move:
12.01%
Sell
41
Liberty Formula One Group (FWONK)
is a Sell
Is Liberty Formula One Group a Buy, Sell or Hold?
- The current Liberty Formula One Group [FWONK] share price is $69.15. The Score for FWONK is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- FWONK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.34. The Score for NVCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FWONK Stock Price Chart
What is Liberty Formula One Group's stock price today?
-
The Liberty Formula One Group share price today is $69.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FWONK is experiencing slight buying pressure.
FWONK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 55.75 | Buy |
| Chaikin Money Flow: | 206071 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.61 - 68.57) | Buy |
| Bollinger Bands (100): | (63.54 - 69.36) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 39.01 | Sell |
| Chaikin Money Flow: | 785705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.43 - 14.65) | Sell |
| Bollinger Bands (100): | (12.92 - 15.44) | Sell |
FWONK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.23 | Buy |
| 20-day SMA: | 67.61 | Buy |
| 50-day SMA: | 68.59 | Buy |
| 200-day SMA: | 67.12 | Buy |
| 8-day EMA: | 68.5 | Buy |
| 20-day EMA: | 68.13 | Buy |
| 50-day EMA: | 67.89 | Buy |
| 200-day EMA: | 67.36 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.2 | Buy |
| 20-day SMA: | 13.58 | Sell |
| 50-day SMA: | 14.54 | Sell |
| 200-day SMA: | 17.95 | Sell |
| 8-day EMA: | 12.42 | Sell |
| 20-day EMA: | 13.17 | Sell |
| 50-day EMA: | 13.96 | Sell |
| 200-day EMA: | 22.83 | Sell |
Liberty Formula One Group Earnings Growth & FWONK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.12 per share, an increase this year of $0.25 per share, and an increase next year of $0.34 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Liberty Formula One Group Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||